OGN
$OGN
Organon & Co.
Women's health pharmaceutical company spun off from Merck with contraceptives and fertility treatments.
HealthcareSubscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
OGN: Cheap Valuation, Debt Questions
Organon ($OGN) trades near multi-year lows with a low P/E and solid ROE, while elevated leverage and a sell-tilted analyst consensus keep the stock in a watchful neutral posture.
Mar 30, 2026